Pfizer Just Paid $330 Million to Skip Cell Therapy's Hardest Step
Pfizer is paying $330M up front, up to $2.6B total, for three in vivo CAR-T programs from China's Starna, a bet it can make cell therapy injectable.

News app with AI key takeaways, personalised feed and daily audio digests
The Yahoo News app, rebuilt with technology from Artifact, uses AI to personalise your feed, add bullet-point Key Takeaways to articles and trending topics, and rewrite headlines readers flag as clickbait. In the US it also offers The Morning Briefing and a personalised afternoon audio summary, Your Daily Digest.
Latest: December 2025: launched Your Daily Digest, a personalised AI audio summary, after The Morning Briefing.
Free and easy with useful audio digests, but AI is layered onto a conventional ad-supported news app and limited to the US.
See all Yahoo News alternatives, ranked →
Thanks! We'll check it against official sources and update the listing if it's confirmed.
Pfizer is paying $330M up front, up to $2.6B total, for three in vivo CAR-T programs from China's Starna, a bet it can make cell therapy injectable.
Intuit is selling Mailchimp to Bending Spoons for about $3.68bn, a third of the $12bn it paid in 2021. Shares fell 13% after hours.
J&J will pay $2.2bn upfront, plus up to $1.125bn in milestones, for Ollin Biosciences and its Phase 3 eye-disease antibody OLN324.